Mode
Text Size
Log in / Sign up
Phase 2 N=154 Randomized Triple-blind Other

Acute and Residual Effects of Caffeinated Beer

Neurobehavioral Manifestations · Drug Related Sleep Disturbance · Alcohol Intoxication

Enrolled (actual)
154
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Lane Position Deviation — -1.25; -1.36; -1.22; -1.21 feet

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Caffeinated Alcoholic Beer (Drug); Non-Caffeinated Alcoholic Beer (Other); Caffeinated Non-Alcoholic Beer (Drug); Non-Caffeinated, Non-Alcoholic Beer (Other)
Age
Adult · 21+ yrs
Sex
All
Sponsor
Boston University
Primary completion
Oct 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Lane Position Deviation
-1.25; -1.36; -1.22; -1.21
SECONDARY
Psycho-motor Vigilance Test (PVT)
278.7; 293.3; 233.1; 241.8

Summary

The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non-caffeinated alcohol, caffeinated placebo, and non-caffeinated placebo. Under the alcohol conditions, participants will receive sufficient alcoholic beverage to attain a blood alcohol concentration (BAC) of .12 g%. Participants will be 144 undergraduate and graduate students, and recent college graduates.

Eligibility Criteria

Inclusion Criteria

  • College students, graduate students, or recent graduates
  • Between the ages of 21 and 30 years inclusive (as verified by valid drivers license)
  • Who, if a student, reports good academic standing
  • Have not been diagnosed with a sleep disorder
  • Are not daily smokers
  • At least occasionally in the past month, consume five drinks (for men) or more (four or more if female [based on Flannery et al 2002]) during a single drinking episode
  • Have a valid drivers license, so as to include only people who know how to drive.

Exclusion Criteria

  • Scores of 5 or more on a screening measure for alcoholism (the short version of the Michigan Alcohol Screening Test [SMAST])
  • A history of counseling or treatment for chronic substance abuse by self-report
  • Daily smoker (to mitigate confounding of caffeine by nicotine withdrawal, or acute nicotine administration, smokers will be excluded from participation)
  • Current use of medications that affect the sleep/wake cycle or daytime alertness or that are contraindicated for alcohol
  • Presence of a health condition that contraindicates alcohol
  • Diagnosis of a sleep disorder (sleep apnea, narcolepsy, periodic limb movement, restless legs syndrome, circadian rhythm disorder, and insomnia)
  • Use of recreational drugs (e.g., marijuana) while participating in the study
  • Working overnight shifts
  • Female and pregnant, nursing, or not using reliable birth control
  • Participants who have traveled across two or more time zones in the last month will be rescheduled for later participation (minimum of 1 month from time-zone travel)
  • On average consume greater than 4 cups of coffee per day (>400 mg/day)
  • Participants who report ever getting motion sick during screening or become motion sick after practicing on the driving simulator during Session 1.
  • Weigh more than 230 Lbs.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00515294). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search